{
    "id": 15690,
    "fullName": "PIK3CA D350G",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA D350G lies within the C2 PI3K-type domain of the Pik3ca protein (UniProt.org). D350G results in increased phosphorylation of Akt in cell culture (PMID: 24265155) and demonstrates increased transformation ability in two different cell lines, as compared to wild-type Pik3ca (PMID: 29533785).",
            "references": [
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                },
                {
                    "id": 4170,
                    "pubMedId": 24265155,
                    "title": "Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24265155"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "D350G",
    "createDate": "12/24/2015",
    "updateDate": "04/29/2018",
    "referenceTranscriptCoordinates": {
        "id": 171636,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179203779A>G",
        "cDna": "c.1049A>G",
        "protein": "p.D350G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10283,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a patient-derived xenograft (PDX) model of endometrial cancer harboring PIK3CA D350G, PIK3CA R93W, and PTEN R130G was sensitive to Miransertib (ARQ092), demonstrating greater than 90% inhibition of tumor growth (PMID: 26469692).",
            "molecularProfile": {
                "id": 27339,
                "profileName": "PIK3CA R93W PIK3CA D350G PTEN R130G"
            },
            "therapy": {
                "id": 635,
                "therapyName": "Miransertib",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8234,
                    "pubMedId": 26469692,
                    "title": "Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26469692"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 15958,
            "profileName": "PIK3CA D350G",
            "profileTreatmentApproaches": [
                {
                    "id": 17394,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA D350G"
                },
                {
                    "id": 17393,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA D350G"
                },
                {
                    "id": 17396,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA D350G"
                },
                {
                    "id": 17392,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA D350G"
                },
                {
                    "id": 17395,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA D350G"
                },
                {
                    "id": 17391,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA D350G"
                },
                {
                    "id": 17397,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA D350G"
                },
                {
                    "id": 17398,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA D350G"
                }
            ]
        },
        {
            "id": 27339,
            "profileName": "PIK3CA R93W PIK3CA D350G PTEN R130G",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 171635,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179203779A>G",
            "cDna": "c.1049A>G",
            "protein": "p.D350G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171637,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179203779A>G",
            "cDna": "c.1049A>G",
            "protein": "p.D350G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171636,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179203779A>G",
            "cDna": "c.1049A>G",
            "protein": "p.D350G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}